PRODUCT INFORMATION

ViraCoat FFP3 Respirator Masks   

COVID-Eliminating & Virucidal     

This next-generation ViraCoat FFP3 Mask has been scientifically demonstrated to have profound antiviral properties against SARS-CoV-2 (including new strains), Influenza (PR8 strain), and Bacteria (E. coli).

• Distinctive green colour is easily identifiable and means you instantly know you are picking up a more effective piece of PPE.
• Lightweight — Weighs less than 6g.
• Reusable — Virucidal properties mean less-frequent replacement may be required throughout the day.
• Ergonomically shaped for maximum comfort and ease of use.
• Adjustable nose bridge to ensure an optimal seal.
• Individually wrapped and packaged in a box with instructions.
• FFP3 filtering efficiency: Filtering ≥99% of aerosols, total inward leakage <2%.
• Certified to EN 149:2001+A1:2009.
• CE 0598.
• UKCA 0120.
• ISO 18184:2019 (Textiles – determination of antiviral activity in textile products).
• ISO 10993-1:2018 (Biological evaluation of medical devices safety, cytotoxicity, dermal & skin sensitisation).
• Head loop for comfort (designed at the request of medical staff).
• Folds flat with a protective five-layer construction.
• High-quality, non-woven, breathable fabric.

Key features of Virucidal, Antiviral & Antimicrobial (Neutrapodal™) Technology:

• Eliminates viruses to an efficacy of 99.9% within 5 minutes of contact.*
• Infused into mask textile material under extreme pressure - creating an extremely durable and virtually irreversible bond between the Neutrapodal™ coating and the mask material at the molecular level.
• Protects against both viruses and bacteria.
• Stringent, comprehensive safety research & development approvals.
• All ViraCoat products are tested using live, current strains of virus and bacteria.
• Tested as effective on all SARS-CoV-2 strains (Omicron (South Africa); Delta (India); Gamma (Brazil); Lambda (Peru); Beta (South Africa); & Alpha (UK)), as well as Influenza strains and E. coli bacteria.